Choreo LLC Takes $677,000 Position in Prestige Consumer Healthcare Inc. (NYSE:PBH)

Choreo LLC purchased a new stake in Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 9,986 shares of the company's stock, valued at approximately $677,000.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Opal Wealth Advisors LLC acquired a new stake in shares of Prestige Consumer Healthcare during the 2nd quarter valued at approximately $26,000. Principal Securities Inc. purchased a new stake in Prestige Consumer Healthcare during the fourth quarter worth $29,000. Quest Partners LLC grew its holdings in Prestige Consumer Healthcare by 2,826.7% in the second quarter. Quest Partners LLC now owns 439 shares of the company's stock valued at $30,000 after purchasing an additional 424 shares during the last quarter. EverSource Wealth Advisors LLC increased its position in shares of Prestige Consumer Healthcare by 80.6% in the first quarter. EverSource Wealth Advisors LLC now owns 466 shares of the company's stock valued at $33,000 after buying an additional 208 shares in the last quarter. Finally, Gladius Capital Management LP acquired a new position in shares of Prestige Consumer Healthcare during the 2nd quarter worth $35,000. Institutional investors and hedge funds own 99.95% of the company's stock.

Wall Street Analyst Weigh In

A number of brokerages recently commented on PBH. DA Davidson increased their price objective on shares of Prestige Consumer Healthcare from $93.00 to $95.00 and gave the company a "buy" rating in a research note on Wednesday, August 28th. StockNews.com cut shares of Prestige Consumer Healthcare from a "strong-buy" rating to a "buy" rating in a research note on Tuesday, May 21st. Finally, Canaccord Genuity Group reaffirmed a "buy" rating and issued a $80.00 target price on shares of Prestige Consumer Healthcare in a research note on Tuesday, May 21st. One research analyst has rated the stock with a hold rating and four have given a buy rating to the stock. According to MarketBeat, Prestige Consumer Healthcare presently has an average rating of "Moderate Buy" and a consensus price target of $98.75.

Prestige Consumer Healthcare Trading Up 1.7 %

Shares of PBH traded up $1.21 on Friday, hitting $74.12. 164,257 shares of the stock traded hands, compared to its average volume of 246,796. Prestige Consumer Healthcare Inc. has a 1 year low of $56.34 and a 1 year high of $75.80. The stock's 50 day moving average is $70.77 and its two-hundred day moving average is $69.56. The firm has a market capitalization of $3.67 billion, a P/E ratio of 17.77, a P/E/G ratio of 2.01 and a beta of 0.48. The company has a quick ratio of 1.90, a current ratio of 3.23 and a debt-to-equity ratio of 0.65.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last issued its quarterly earnings results on Thursday, August 8th. The company reported $0.90 earnings per share for the quarter, topping analysts' consensus estimates of $0.86 by $0.04. The company had revenue of $267.10 million for the quarter, compared to analyst estimates of $260.54 million. Prestige Consumer Healthcare had a return on equity of 12.55% and a net margin of 18.43%. The business's revenue for the quarter was down 4.4% compared to the same quarter last year. During the same quarter in the prior year, the company posted $1.06 EPS. As a group, sell-side analysts predict that Prestige Consumer Healthcare Inc. will post 4.42 earnings per share for the current year.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.